Dr. Sanati is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4921 Parkview Pl
Saint Louis, MO 63110Phone+1 314-362-5641Fax+1 314-362-0369- Is this information wrong?
Education & Training
- Yale-New Haven Medical CenterFellowship, Gynecologic Pathology, 2008 - 2009
- Washington University/B-JH/SLCH ConsortiumFellowship, Cytopathology, 2006 - 2007
- Washington University/B-JH/SLCH ConsortiumFellowship, Selective Pathology, 2005 - 2006
- University of Texas Medical Branch HospitalsResidency, Pathology-Anatomic and Clinical, 2001 - 2005
- Iran University of Medical SciencesClass of 1993
Certifications & Licensure
- CA State Medical License 2015 - 2025
- MO State Medical License 2007 - 2020
- IL State Medical License 2016 - 2020
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Cytopathology
Clinical Trials
- PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer Start of enrollment: 2013 Apr 10
- Paclitaxel and BKM120 Before Surgery in Treating Patients With Stage II or III Estrogen Receptor-Positive and HER2-Negative Breast Cancer Start of enrollment: 2014 Aug 01
- Single Fraction High-Gradient Partial Breast Irradiation in Treating Patients With Low-Risk Stage 0-I Breast Cancer Start of enrollment: 2014 Apr 02
- Join now to see all
Publications & Presentations
PubMed
- Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or...Cynthia X Ma, Vera J Suman, Souzan Sanati, Kiran Vij, Meenakshi Anurag, A Marilyn Leitch, Gary W Unzeitig, Jeremy Hoog, Aranzazu Fernandez-Martinez, Cheng Fan, Richard...> ;JAMA Oncology. 2024 Mar 1
- 13 citationsInterobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association w...Mieke R Van Bockstal, Aline François, Serdar Altinay, Laurent Arnould, Maschenka Balkenhol, Glenn Broeckx, Octavio Burguès, Cecile Colpaert, Franceska Dedeurwaerdere, ...> ;Modern Pathology. 2021 Jul 3
- 5 citationsEarly Assessment Window for Predicting Breast Cancer Neoadjuvant Therapy using Biomarkers, Ultrasound, and Diffuse Optical TomographyQuing Zhu, Foluso O. Ademuyiwa, Catherine A. Young, Catherine M. Appleton, Matthew F. Covington, Cynthia X. Ma, S Sanati, Ian S. Hagemann, Atahar Mostafa, K. M. Shihab...> ;Breast Cancer Research and Treatment. 2021 May 10
- Join now to see all
Journal Articles
- Proteogenomic Integration Reveals Therapeutic Targets in Breast Cancer XenograftsSouzan Sanati, Jana W Qiao, Xian Chen, Matthew J Ellis, Cynthia Ma, Nature
Hospital Affiliations
- Siteman Cancer CenterSaint Louis, Missouri
- Cedars-Sinai Medical CenterLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: